PRESS-RELEASE ·Filed Sep 17, 2026
Press release · Earnings
Actionable Insight • Neutral
Monitor upcoming Q3 2026 earnings for revenue and procedure volume updates; clinical data may support surgeon adoption but lacks near-term revenue catalyst.
Latest settled — T+20d
TMCI ▼ -13.81% at T+20d
NEUTRAL call -13.81% · α vs SPY -14.01% · entry $4.49 → $3.87
Latest observation: T+25 -1.96% FF3 residual α
T+1d
-0.22%
call -0.22% · α -1.77%
$4.48
settled 6w ago
T+5d
+0.22%
call +0.22% · α -1.05%
$4.50
settled 5w ago
T+20d
-13.81%
call -13.81% · α -14.01%
$3.87
settled 12d ago
T+60d
Pending
in 6w
Price Chart
Loading chart...
Executive Summary
Treace Medical Concepts presented positive 5-year ALIGN3D Lapiplasty data at AOFAS 2026, showing low recurrence rates and sustained outcomes. The filing is a clinical data update, not an earnings release, and contains no financial results or guidance.
Key Facts
- 5-year ALIGN3D Lapiplasty data showed 0.8% recurrence rate (HVA>20°) and 5.3% (HVA>15°) at 5 years
- MTA3D Adductoplasty 2-year interim data showed maintained correction through 24 months
- SPRINT SpeedPlate study showed 96.6% union rate at 12 months
- All studies presented at AOFAS Annual Meeting in Seattle
- No financial results, guidance, or consensus data provided in this filing
Financial Impact
No financial figures disclosed; clinical data only
Risk Factors
- Clinical data does not guarantee commercial adoption or revenue growth
- No financial guidance or consensus data provided in this filing
Investment Themes
Healthcare & Medical Devices
Documents Analyzed
This report is based on 1 press release from GlobeNewswire.
| Document | Accession Number |
|---|---|
| PRESS-RELEASE Data (Synthetic) | press-3364415 |
7 reports for TMCI
Track record builds as more directional reports settle.
Filters
Rows
| Type | Now | ||||
|---|---|---|---|---|---|
Sep 17, 2026 5w ago | Press Release | $4.49 | awaiting T+60 | — | $4.55 (+1.34%) |
Aug 7, 2026 11w ago | 8-K | $4.76 | awaiting T+60 | — | $4.55 (−4.41%) |
Jul 13, 2026 15w ago | Court Ruling | $4.44 $3.89 | ▲ +12.39% | ▲ +15.76% | $4.55 (−2.48%) |
May 8, 2026 24w ago | Press Release | $2.01 $4.74 | ▼ −135.82% | ▼ −130.98% | $4.55 (−126.37%) |
Apr 24, 2026 26w ago | Press Release | $1.98 $4.23 | ▲ +113.64% | ▲ +108.56% | $4.55 (+129.80%) |
Apr 9, 2026 28w ago | 8-K | $1.53 $4.56 | ▲ +198.04% | ▲ +187.26% | $4.55 (+197.39%) |
Apr 6, 2026 29w ago | DEFA14A | $1.44 $4.23 | ▲ +193.75% | ▲ +180.28% | $4.55 (+215.97%) |
Showing 7 of 7
US Market Status
Market Closed — Opens Wed (< 1m)
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers